FAA finally publishes its secret medication approval list for pilots

What it does

This bill requires the FAA to publish and maintain a publicly accessible list of medications that the agency has approved for pilots and air traffic controllers seeking medical certification, along with medications the FAA has prohibited. The list must be user-friendly, updated annually, and include information about stabilization periods and guidance for doctors. The goal is to give airmen, controllers, and medical professionals clear, transparent information about which medications are safe under FAA rules.

Why we flagged it

The bill's sole operative mechanism is mandating public disclosure of information the FAA already possesses. It is a transparency reform, not a substantive policy change to medication approval standards or medical certification rules.

What the text implies

• Publishing the 'Do Not Issue' list may reduce off-label prescribing attempts and associated medical certification denials, potentially lowering administrative burden on both the FAA and applicants.
• Standardized, published guidance to doctors may reduce variation in how medical providers advise patients on FAA-approved treatments, improving consistency across the aviation medical community.

The full analysis lists 3 implications of this text.

Who it affects

Ordinary citizens—including pilots, controllers, and their doctors—gain transparency and clarity about FAA medication rules that directly affect their ability to work and receive appropriate medical care. The bill removes information asymmetry (the FAA had compiled this list internally but did not publish it), enabling informed decision-making and reducing arbitrary denials or confusion.